Trial intelligence / Profile preview

Ziprasidone in Children With Autism

NCT00208559Phase 2Completed

Sponsor
Drexel University
Start
Feb 2002
Primary completion
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ziprasidone in Autism Spectrum Disorder (ASD), sponsored by Drexel University. Started Feb 2002; status: completed.

02

Drugs

ziprasidone
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT00208559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00208559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call